The results showed that the level of EIF5A2 was higher in 374 cancer than 50 normal sample in LIHC (Figure S1).To confirm whether EIF5A2 was the genuine target gene of miR‐383, we first examined the protein and mRNA expression of EIF5A2 in HCC cell lines. This evidence concerns the gene EIF5A2 and hepatocellular carcinoma.